Article
The impact of KRAS mutations on VEGF-A production and tumour vascular network.
BMC cancer - 18 Mar 2013
Figueras Agnès, Arbos Maria Antonia, Quiles Maria Teresa, Viñals Francesc, Germà Josep Ramón, Capellà Gabriel
Abstract excerpt
BACKGROUND: The malignant potential of tumour cells may be influenced by the molecular nature of KRAS mutations being codon 13 mutations less aggressive than codon 12 ones. Their metabolic profile is also different, with an increased anaerobic glycolytic metabolism in cells harbouring codon 12 KRAS mutations compared with cells containing codon 13 mutations. We hypothesized that this distinct metabolic behaviour...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
